You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The money will be used to fund amyotrophic lateral sclerosis biomarker research, a natural history study, and a biosample and genomics core.
In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.
In PNAS this week: modeling of Rift Valley Fever spillover, Asian mosquito could pose malaria threat, and more.
In Science this week: crystal structures of single-stranded RNA bacteriophages found through metagenomic studies, more.
The study also found that certain genes may influence multiple complex traits, while others only affect one phenotype, making them worthwhile therapeutic targets.
The partners will use Medidata's machine learning-based biomarker discovery platform to investigate the amyotrophic lateral sclerosis disease process.
In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.
CNN reports that an experimental treatment is showing promise for treating the genetic form of amyotrophic lateral sclerosis.
The ALS Association is committing $3.5 million, including a $1 million commitment from its Greater New York chapter, while the Tow Foundation is contributing $2.5 million.
Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.
According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.
In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.
Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.